Moody's [MCO] vs CME [CME] Detailed Stock Comparison
Moody's
NYSE
Loading...
CME
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Moody's wins in 6 metrics, CME wins in 14 metrics, with 0 ties. CME appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Moody's | CME | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 40.66 | 26.17 | CME |
| Price-to-Book Ratio | 21.88 | 3.45 | CME |
| Debt-to-Equity Ratio | 179.87 | 13.60 | CME |
| PEG Ratio | 6.48 | 1.67 | CME |
| EV/EBITDA | 26.98 | 21.44 | CME |
| Profit Margin (TTM) | 29.18% | 58.59% | CME |
| Operating Margin (TTM) | 44.68% | 66.87% | CME |
| EBITDA Margin (TTM) | 44.68% | 66.87% | CME |
| Return on Equity | 53.02% | 13.61% | Moody's |
| Return on Assets (TTM) | 12.75% | 1.74% | Moody's |
| Free Cash Flow (TTM) | $2.52B | $3.60B | CME |
| Dividend Yield | 0.56% | 4.30% | CME |
| 1-Year Return | 5.32% | 17.93% | CME |
| Price-to-Sales Ratio (TTM) | 11.85 | 15.14 | Moody's |
| Enterprise Value | $91.32B | $97.48B | CME |
| EV/Revenue Ratio | 12.50 | 15.15 | Moody's |
| Gross Profit Margin (TTM) | 74.24% | 86.90% | CME |
| Revenue per Share (TTM) | $40 | $18 | Moody's |
| Earnings per Share (Diluted) | $11.85 | $10.16 | Moody's |
| Beta (Stock Volatility) | 1.41 | 0.43 | CME |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Moody's vs CME Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Moody's | 0.60% | 1.74% | -2.30% | -3.96% | 9.64% | 2.58% |
| CME | -0.29% | -2.08% | -1.74% | -4.35% | -1.38% | 13.73% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Moody's | 5.32% | 97.60% | 64.57% | 390.53% | 1,703.12% | 850.87% |
| CME | 17.93% | 55.76% | 56.23% | 199.74% | 404.33% | 294.38% |
News Based Sentiment: Moody's vs CME
Moody's
News based Sentiment: POSITIVE
October proved to be a very positive month for Moody's, with strong financial results, multiple analyst upgrades, and increased institutional investment. The company is demonstrating successful diversification and growth in key areas like AI, making it a compelling investment story.
CME
News based Sentiment: POSITIVE
CME Group is demonstrating strong financial performance and strategic growth, particularly in the rapidly expanding cryptocurrency market. The upcoming earnings report and new product launches represent key catalysts for continued positive momentum, despite some mixed signals from institutional investors.
Performance & Financial Health Analysis: Moody's vs CME
| Metric | MCO | CME |
|---|---|---|
| Market Information | ||
| Market Cap | $87.18B | $96.97B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 819,296 | 1,918,300 |
| 90 Day Avg. Volume | 709,945 | 1,895,850 |
| Last Close | $485.04 | $264.67 |
| 52 Week Range | $378.71 - $531.93 | $213.94 - $290.79 |
| % from 52W High | -8.82% | -8.98% |
| All-Time High | $531.93 (Feb 10, 2025) | $290.79 (Jun 02, 2025) |
| % from All-Time High | -8.82% | -8.98% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.10% |
| Quarterly Earnings Growth | 0.05% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.59% |
| Operating Margin (TTM) | 0.45% | 0.67% |
| Return on Equity (TTM) | 0.53% | 0.14% |
| Debt to Equity (MRQ) | 179.87 | 13.60 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $22.02 | $77.13 |
| Cash per Share (MRQ) | $12.77 | $5.82 |
| Operating Cash Flow (TTM) | $2.68B | $4.20B |
| Levered Free Cash Flow (TTM) | $2.10B | $2.92B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.56% | 4.30% |
| Last 12-Month Dividend | $2.64 | $11.85 |
Valuation & Enterprise Metrics Analysis: Moody's vs CME
| Metric | MCO | CME |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 40.66 | 26.17 |
| Forward P/E | 36.17 | 25.64 |
| PEG Ratio | 6.48 | 1.67 |
| Price to Sales (TTM) | 11.85 | 15.14 |
| Price to Book (MRQ) | 21.88 | 3.45 |
| Market Capitalization | ||
| Market Capitalization | $87.18B | $96.97B |
| Enterprise Value | $91.32B | $97.48B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 12.50 | 15.15 |
| Enterprise to EBITDA | 26.98 | 21.44 |
| Risk & Other Metrics | ||
| Beta | 1.41 | 0.43 |
| Book Value per Share (MRQ) | $22.02 | $77.13 |
Financial Statements Comparison: Moody's vs CME
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MCO | CME |
|---|---|---|
| Revenue/Sales | $1.92B | $1.64B |
| Cost of Goods Sold | $491.00M | $206.70M |
| Gross Profit | $1.43B | $1.44B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $881.00M | $1.11B |
| EBITDA | $1.04B | $476.30M |
| Pre-Tax Income | $804.00M | $1.24B |
| Income Tax | $179.00M | $288.60M |
| Net Income (Profit) | $625.00M | $956.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MCO | CME |
|---|---|---|
| Cash & Equivalents | $2.14B | $1.41B |
| Total Current Assets | $4.57B | $123.45B |
| Total Current Liabilities | $2.92B | $121.42B |
| Long-Term Debt | $7.03B | $3.42B |
| Total Shareholders Equity | $3.86B | $27.03B |
| Retained Earnings | $16.53B | $4.69B |
| Property, Plant & Equipment | $2.40B | $371.20M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MCO | CME |
|---|---|---|
| Operating Cash Flow | $1.04B | $838.30M |
| Capital Expenditures | N/A | $-14.20M |
| Free Cash Flow | $672.00M | $1.10B |
| Debt Repayment | $-700.00M | $-750.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MCO | CME |
|---|---|---|
| Shares Short | 2.30M | 4.63M |
| Short Ratio | 3.91 | 2.42 |
| Short % of Float | 0.01% | 0.01% |
| Average Daily Volume (10 Day) | 819,296 | 1,918,300 |
| Average Daily Volume (90 Day) | 709,945 | 1,895,850 |
| Shares Outstanding | 180.31M | 359.61M |
| Float Shares | 165.78M | 358.74M |
| % Held by Insiders | 0.14% | 0.00% |
| % Held by Institutions | 0.79% | 0.92% |
Dividend Analysis & Yield Comparison: Moody's vs CME
| Metric | MCO | CME |
|---|---|---|
| Last 12-Month Dividend | $2.64 | $11.85 |
| Last 12-Month Dividend Yield | 0.56% | 4.30% |
| 3-Year Avg Annual Dividend | $2.92 | $10.10 |
| 3-Year Avg Dividend Yield | 0.22% | 0.91% |
| 3-Year Total Dividends | $8.75 | $30.30 |
| Ex-Dividend Date | Feb 25, 2025 | Sep 09, 2025 |